Moreover, ginsenoside Rg3 can upregulate miR‐429 to inhibit SOX2 and the PI3K/Akt/mTOR signaling axis, thereby reducing cisplatin resistance in gastric cancer cells (Wang et al. 2022). The gene discussed is SOX2; the disease is gastric cancer.